|
US2010144602A1
|
|
Methods of Inhibiting Metastatic Cancer by Administration of Streptolysin O
|
|
US2007219119A1
|
|
Method of treatment of tendonitis by administration of streptolysin O
|
|
WO2007046966A2
|
|
Methods for the treatment of influenza
|
|
US2005032701A1
|
|
Use of calmodulin to promote bone regeneration
|
|
AU2004206971A1
|
|
Method of treatment of conditions by administration of streptolysin O
|
|
US2004127409A1
|
|
Method of treatment of psychological conditions by administration of nerve growth factor
|
|
US2004072731A1
|
|
Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin
|
|
US6998121B2
|
|
Method of treatment of connective tissue disorders by administration of streptolysin O
|
|
CA2473694A1
|
|
Use of calmodulin to promote bone regeneration
|
|
US6713058B2
|
|
Methods for alleviating symptoms associated with neuropathic conditions comprising administration of low levels of antibodies
|
|
US2002115632A1
|
|
Treatment of symptoms of asthma and allergies
|
|
US6436401B1
|
|
Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies
|
|
WO0188102A1
|
|
Method for preventing allograft rejection
|
|
US6294171B2
|
|
Methods for treating disease states comprising administration of low levels of antibodies
|
|
WO0147550A1
|
|
Method for treatment of canine distemper
|
|
US6437093B1
|
|
Methods of treatment comprising administration of Substance P
|
|
IL138265A
|
|
Use of dna for the manufacture of a medicament for treating respiratory distress and relieving respiratory congestion
|
|
WO0119398A1
|
|
Method for treatment of symptoms of central nervous system disorders
|
|
AU4800500A
|
|
Method for treatment of lyme disease
|
|
CA2323213A1
|
|
Treatment of respiratory disease and otitis media
|
